12.87
price down icon4.81%   -0.65
 
loading

Finanzdaten der Nextcure Inc-Aktie (NXTC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
9.08%
9.757
8.945 27.29 11.62 12.46
Operating Income/Loss
9.08%
-9.757
-8.945 -27.29 -11.62 -12.46
Income/Loss From Continuing Operations Before Tax
9.42%
-9.436
-8.624 -26.81 -10.98 -11.60
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
9.42%
-9.436
-8.624 -26.81 -10.98 -11.60
Net Income/Loss
9.42%
-9.436
-8.624 -26.81 -10.98 -11.60
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
85.81%
0.3796
2.6761 2.3747 28.01 0.014
Diluted Average Shares
85.81%
0.3796
2.6761 2.3747 28.01 0.014
Basic Earnings Per Share
74.84%
-0.81
-3.22 -11.29 -0.39 -0.41
Diluted Earnings Per Share
74.84%
-0.81
-3.22 -11.29 -0.39 -0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):